| Saudi Arabia | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 96.4 (2020) [174/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 3.4 (2020) [98/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.9 (2020) [120/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 28.8 (2020) [153/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 2.8 (2020) [180/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 11.5 (2020) [100/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 10.9 (2020) [59/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.8 (2020) [64/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 3.0 (2020) [85/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 0.8 (2020) [148/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 5.6 (2020) [80/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.7 (2020) [110/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 5.2 (2020) [97/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 5.1 (2020) [139/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 1.4 (2020) [165/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.0 (2020) [120/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 1.4 (2020) [28/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 7.8 (2020) [64/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.0 (2020) [150/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.1 (2020) [160/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 3.8 (2020) [155/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 2.2 (2020) [132/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 7.0 (2020) [169/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 2.7 (2020) [170/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.8 (2020) [101/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 7.5 (2020) [43/184countries] | | |
|
| Saudi Arabia | | |
Suicide, age-standardized (per 100 000 population) | 5.43 (2019) [133/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 7.79 (2019) [136/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.91 (2019) [146/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 3.88 (2019) [126/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 6.16 (2019) [114/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.43 (2019) [145/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 8.77 (2019) [70/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 13.11 (2019) [75/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 2.96 (2019) [97/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 10.01 (2019) [93/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 13.69 (2019) [100/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 3.70 (2019) [92/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 8.56 (2019) [118/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 11.34 (2019) [133/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 3.03 (2019) [129/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 7.20 (2019) [137/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 9.74 (2019) [140/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 2.24 (2019) [145/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 5.96 (2019) [151/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 9.05 (2019) [154/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.16 (2019) [155/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 5.59 (2019) [166/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 9.29 (2019) [165/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 1.92 (2019) [166/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 9.72 (2019) [163/183countries] | | |
|
|